Drug
Tacabrutideg
Tacabrutideg: highest development phase Phase 3, developed by BeOne Medicines. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- BeOne Medicines
Trials
| Drug | Phase | Indication |
|---|---|---|
| Tacabrutideg NCT06846671 | Phase 3 | CLL |
Latest
No recent events.
Follow Tacabrutideg on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.